Innovent Biologics (HK:1801) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Innovent Biologics has announced the grant of 55,900 share options and 488,200 restricted shares to its non-senior management employees under its 2024 Share Scheme. The options, priced at HK$38.38 per share, will vest over four years contingent upon performance targets. This strategic move aims to incentivize employees while aligning their performance with the company’s objectives.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.
